| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/07/2009 | CN101340913A Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 01/07/2009 | CN101337966A Method for preparing high-purity irinotecan |
| 01/07/2009 | CN101337965A Method for preparing camptothecin derivates |
| 01/07/2009 | CN101337928A Quinoline compounds, synthesizing method, applications in synthesis of alkaloid of camptothecins |
| 01/07/2009 | CN101337900A Method of synthesizing camptothecin-relating compounds |
| 01/07/2009 | CN100448878C Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 01/07/2009 | CN100448877C 3-phenyl substituted 3-substituted-4ketolactams and ketolactones |
| 01/07/2009 | CN100448687C Imaging system |
| 01/07/2009 | CN100448487C Method of treating estrogen receptor positive carcinoma |
| 01/06/2009 | US7473783 Bicyclic pyrazolo protein kinase modulators |
| 01/06/2009 | US7473694 excellent inhibitory activity against MAPKAP-K2; inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth; (4-ethoxyphenyl)(5-piperidin-3-yl-6,7-dihydro-5H-1,4,5,8a-tetraaza-s-indacen-8-yl)amine |
| 01/06/2009 | US7473691 Pyrazole compounds useful as protein kinase inhibitors |
| 01/06/2009 | CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 01/06/2009 | CA2213519C Suksdorfin analogs, compositions thereof, and methods for making and using thereof |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/01/2009 | US20090005356 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators |
| 12/31/2008 | WO2009003077A1 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
| 12/31/2008 | WO2009001129A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
| 12/31/2008 | WO2009000877A1 Cysteine protease inhibitors |
| 12/31/2008 | WO2009000757A1 Piperazine compounds with herbicidal action |
| 12/31/2008 | WO2009000412A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
| 12/31/2008 | EP2009015A1 An improved process for the preparation of galantamine hydrobromide |
| 12/31/2008 | EP2009005A1 Azolecarboxamide derivative |
| 12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
| 12/31/2008 | EP2007762A2 Mono and di-substituted oxycodone compounds and compositions |
| 12/31/2008 | EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
| 12/31/2008 | EP2007386A2 Camptothecin-analog with a novel, flipped lactone-stable, e-ring and methods for making and using same |
| 12/31/2008 | EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 12/31/2008 | EP1648923B1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 12/31/2008 | EP1648905B1 Thienopyridine and furopyridine kinase inhibitors |
| 12/31/2008 | EP1276741B1 Phenyl substituted 4-hydroxy tetrahydropyridone and its use as pesticide and herbicide |
| 12/31/2008 | CN101336245A Process for preparing unsaturated imidoalkoxysilanes |
| 12/31/2008 | CN100447144C Process for the stereoselective synthesis of lactones |
| 12/31/2008 | CN100447140C 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
| 12/31/2008 | CA2693142A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
| 12/31/2008 | CA2690344A1 Cysteine protease inhibitors |
| 12/31/2008 | CA2689945A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
| 12/31/2008 | CA2686224A1 Piperazine compounds having herbicidal action |
| 12/30/2008 | US7470797 Nuclear hormone receptor modulator; anticarcinogenic agent; 3-(4-Cyano-3-trifluoromethylphenylcarbamoyl containing 3-carboxy-14-dimethyl-5-oxa-7-oxybicyclo(2.2.2) heptane compound |
| 12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 12/30/2008 | US7470717 Indazole derivatives |
| 12/30/2008 | US7470712 Amino-benzazoles as P2Y1 receptor inhibitors |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/30/2008 | US7470698 Adenosine A3 receptor modulators |
| 12/30/2008 | US7470691 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 12/30/2008 | CA2395652C New derivatives of benzo[b]pyrano[3,2-h]acridin-7-one, process for preparing them, and pharmaceutical compounds containing them |
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/30/2008 | CA2275192C Novel preparation method for derivatives of 4-phenyl-1,2,3,6-tetrahydropyridine and the intermediate products activated thereby |
| 12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/25/2008 | US20080318997 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 12/25/2008 | US20080318903 Methods for treating cancer |
| 12/25/2008 | US20080318902 Triheterocyclic compounds and compositions thereof |
| 12/24/2008 | WO2008157211A1 Crystalline forms of (3aalpha,4beta,5alpha,7beta,7aalpha)-4-(octahydro-5-ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,-7-ep0xy-2h-isoind0l-2-yl)- |
| 12/24/2008 | WO2008155017A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases |
| 12/24/2008 | WO2008155016A1 Substituted furopyrimidines and use thereof |
| 12/24/2008 | WO2008131119A3 Composition and method for cancer treatment and prevention |
| 12/24/2008 | WO2008060476A3 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 12/24/2008 | EP1917267B1 Crystal form of asenapine maleate |
| 12/24/2008 | EP1603555B1 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/24/2008 | EP1545502A4 Keto cannabinoids with therapeutic indications |
| 12/24/2008 | EP1017399B1 Camptothecin analogs and methods of preparation thereof |
| 12/24/2008 | CA2690545A1 Substituted bicyclic heteroaryl compounds and their use |
| 12/24/2008 | CA2690527A1 Substituted furopyrimidines and use thereof |
| 12/23/2008 | US7468438 Demethylation of reserpic acid lactone to give 11-O-demethyl reserpic acid lactone, converting to deserpidic acid lactone, hydrolysis to methyl deserpidate esterification of methyl deserpidate with trimethoxybenzoic acid to give deserpidine |
| 12/23/2008 | US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 12/23/2008 | US7468376 Pyrazolopyridine derivates |
| 12/23/2008 | US7468373 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 12/23/2008 | US7468371 Tricyclic pyrazole kinase inhibitors |
| 12/23/2008 | US7468366 Cytotoxic agents |
| 12/18/2008 | WO2008153858A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
| 12/18/2008 | WO2008152394A1 Pharmaceutical compounds |
| 12/18/2008 | WO2008151927A2 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| 12/18/2008 | WO2008048867A3 Bicyclic heteroaromatic compounds |
| 12/18/2008 | US20080312224 Oxaphenanthrene Derivatives |
| 12/18/2008 | US20080312218 Fused tetracyclic mglur1 antagonists as therapeutic agents |
| 12/18/2008 | US20080311041 Water-Soluble, Fluorescent Compounds for Detection of Potassium Ions |
| 12/18/2008 | DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 12/18/2008 | DE102007027800A1 Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung Substituted bicyclic heteroaryl compounds and their use |
| 12/18/2008 | DE102007027799A1 Substituierte Furopyrimidine und ihre Verwendung Substituted Furopyrimidine and their use |
| 12/18/2008 | CA2694860A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
| 12/17/2008 | EP2003135A2 Process for producing optically active chromene oxide compound |
| 12/17/2008 | EP1603919B1 7-imino derivatives of camptothecin having antitumor activity |
| 12/17/2008 | CN101325952A Agent for prevention and treatment of acute renal failure |
| 12/17/2008 | CN101323618A Method for separating and preparation of Gelsemium elegans alkaloid monomer by high speed counter current chromatography |
| 12/17/2008 | CN100443487C N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 12/17/2008 | CN100443486C 7-esterified and 7,20-double esterified camptothecine derivant and method for preparing the same and pharmaceutical combination and uses thereof |
| 12/17/2008 | CN100443481C Imidazolyl-cyclic acetals |
| 12/17/2008 | CN100443480C Tricyclic compound and its preparation and use |
| 12/17/2008 | CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/16/2008 | US7465747 Fluorescent label compounds |
| 12/16/2008 | US7465743 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors |
| 12/16/2008 | US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative |
| 12/16/2008 | US7465740 2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/11/2008 | WO2008151303A1 Long wavelength fluorogenic intercellular ion indicators |
| 12/11/2008 | WO2008150848A1 Antidepressant heteroaryl derivatives of heterocycle-fused benzodioxans |
| 12/11/2008 | WO2008150000A1 Method for production of optically active etodolac |
| 12/11/2008 | WO2008148260A1 A novel crystal form of irinotecan hydrochloride and its preparation |
| 12/11/2008 | WO2008082009A3 Fused substituted aminopyrrolidine derivative |